Inari Medical Inc
NARI
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.68B
Close$
$-34.71
143.4% downside
Current Fair Value
143.4% downsideOvervalued by 143.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.68 Billion |
|---|---|
| Enterprise Value | $4.67 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 1.03 |
| Outstanding Shares | 58,366,364 |
Return
| Return on Equity | -18.08% |
|---|---|
| Return on Assets | -11.27% |
| Return on Invested Capital | -6.71% |
Valuation & Multiples
| P/E Ratio | -2775.03 |
|---|---|
| PEG | 407.57 |
| Price to Sales | 8.89 |
| Price to Book Ratio | 11.42 |
| Enterprise Value to Revenue | 8.14 |
| Enterprise Value to EBIT | -127.04 |
| Enterprise Value to Net Income | -60 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Inari Medical Inc
456 employeesInari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based...